| abstract |
The invention relates to an application of GABRD methylation as an anti-heroin relapse target spot, and compared with the prior art, the invention has the advantages that: according to the invention, research finds that the heroin relapse behavior can be effectively reduced by reducing the GABRD gene methylation level, and the research and development values and the development significance of the drug for treating heroin relapse by taking the GABRD gene methylation as a target point are important. |